Business Wire

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address ...
Yahoo Finance

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

CAMBRIDGE, Mass., September 17, 2025--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small ...